Revisiting predictors of worse atrioventricular valve and left ventricular systolic function following pacemaker therapy

Author:

Sasaki Kenichi1ORCID,Togashi Daisuke1ORCID,Nakajima Ikutaro1,Nakayama Yui1,Harada Tomoo1,Akashi Yoshihiro J.1

Affiliation:

1. Division of Cardiology Department of Internal Medicine St. Marianna University School of Medicine Kawasaki Japan

Abstract

AbstractBackgroundPredictors of worsening atrioventricular valve regurgitation and left ventricular (LV) systolic function after implantation of a leadless pacemaker (LPM) remain unclear compared with those of a transvenous pacemaker (TPM).MethodsWe retrospectively analyzed 205 patients who were newly implanted with a permanent pacemaker (119 LPMs and 86 TPMs) and underwent transthoracic echocardiography before and 8 ± 5 months after implantation. We evaluated the worsening of tricuspid and mitral regurgitation (TR and MR), defined as at least one‐grade aggravation in severity, and changes in LV ejection fraction (LVEF).ResultsWorsening TR occurred more frequently in the LPM group compared to the TPM group (33% vs. 20%, p = .04); however, there was no significant difference between the two groups regarding worsening MR (26% vs. 18%, p = .18) and LVEF change (–2 ± 10% vs. –3 ± 8%, p = .40). In multivariable analysis, independent predictors for worsening TR, MR, and LVEF after implantation were found to be (1) the change from sinus rhythm at baseline to atrioventricular asynchronous right ventricular (RV) pacing (odds ratio [OR]: 5.68, 95% confidence interval [CI]: 1.94–16.70, p < .01); (2) the change from non‐pacing ventricular contraction at baseline to RV pacing (OR: 2.42, 95% CI: 1.12–5.24, p = .02); and (3) a higher RV pacing burden (β: –0.05, 95% CI: −0.08–−0.02, p < .01), respectively.ConclusionWorsening TR, MR, and LVEF after pacemaker implantation were not associated with the type of pacing device but loss of atrioventricular synchrony or dependency on RV pacing.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3